title: [Drug-related hyperkalemia resulted from spironolactone and angiotensin converting enzyme inhibitors therapy].
abstract: A case of drug-related hyperkaliemia linked to treatment with angiotensin converting enzyme inhibitors and spironolactone simultaneously. The paper presents the case of drug-related hiperkaliemia induced by captopril and spironolactone combined treatment in a patient with early stage of renal failure.
authors.affiliation: I Oddziału Chorób Wewnetrznych Szpitala Slaskiego w Cieszynie.
authors.forename: M
authors.initials: M
authors.lastname: Dutka
authors.forename: T
authors.initials: T
authors.lastname: Dzielski
authors.forename: J
authors.initials: J
authors.lastname: Wojciechowska
authors.forename: L
authors.initials: L
authors.lastname: Heller
authors.forename: M
authors.initials: M
authors.lastname: Trybus
mesh_terms: D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects*; D004232:Diuretics / Q000009:adverse effects*; D006801:Humans; D006947:Hyperkalemia / Q000139:chemically induced*; D008297:Male; D051437:Renal Insufficiency / Q000188:drug therapy; D013148:Spironolactone / Q000009:adverse effects*
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D004232:Diuretics; D013148:Spironolactone